期刊文献+

浅析电化学发光免疫分析及在肿瘤标记物方面的应用 被引量:1

Analysis of Electrochemical Luminescence Immunoassay and Its Application in Tumor Marker
下载PDF
导出
摘要 目的分析电化学发光免疫分析仪在肿瘤标记物检测方面的应用。方法选择我院于2016年1-6月所接治的肝癌患者80例为主要研究对象,随机分为观察组与对照组,各组40例。观察组使用电化学光分析检测,对照组使用酶联免疫法检测,比较CEA以及CA15-3两类肿瘤标记物检测情况。结果观察组患者血液中癌抗原15-3以及癌胚抗原都较对照组高,其差异具有统计学意义(P〈0.05)。观察组患者血清中肿瘤标记物检测阳性率CEA为95.00%,CA15-3为97.50%,对照组分别为60.00%、55.00%,差异均具有统计学意义(P〈0.05)。结论借助电化学发光免疫分析法可实现对肿瘤标记物的有效检测。 Objective To analyze the application of the electrochemical immunoassay analyzer in the detection of tumor markers. Methods 80 cases of patients with liver cancer were selected as the main research object inour hospital from January to June 2016, randomly divided into experimental group and control group, 40 cases in each group. The observation group was detected by electrochemical light analysis, and the control group was detected by enzyme-linked immunosorbent assay, and the detection of CEA and CA15-3 tumor markers were compared between the two groups. Results In the observation group, the blood cancer antigen 15-3 and the cancer embryo antigen were significantly higher than those in the control group, the difference was statistically significant(P〈0.05). The positive rate CEA of tumor markers in the observation group was 95.00%, CA15-3 was 97.50%, and the control group was 60.00% and 55.00%, and the difference was statistically significant(P〈0.05). Conclusion The effective detection of tumor markers can be achieved by the use of the electrochemical luminescence immunoassay.
作者 杨国东
出处 《中国继续医学教育》 2016年第30期40-41,共2页 China Continuing Medical Education
关键词 电化学发光免疫 分析 肿瘤标记物 Electrochemical luminescence immunoassay Analysis Tumor marker
  • 相关文献

参考文献9

二级参考文献59

  • 1杨贤斌.全面生化反应和血清学检验在沙门菌临床检验中的应用效[J].求医问药(下半月),2013(9):175-176. 被引量:9
  • 2渡边弘之,韩少良.CA19-9和CA50[J].日本医学介绍,2005,26(2):55-56. 被引量:2
  • 3徐立根.ELISA、MAIA、CLIA和TRFIA试剂盒质量标准探讨[J].放射免疫学杂志,2006,19(3):230-234. 被引量:15
  • 4李斌,卢景琛,罗建远,刘祺,贺玉香.血清CEA、CA199表达与胃癌细胞浸润转移的相关性研究[J].实用肿瘤杂志,2007,22(4):321-323. 被引量:21
  • 5陈文斌,潘祥林.诊断学[M].第6版.北京:人民卫生出版社,2004:457-459.
  • 6Kopmwski H,Hedym M,Stepiewski Z,et al.Specific antigen in serum of patients with colon carcinoma[J].Science,1981,212(4490):53-55.
  • 7Grinbaum R,Nissan A,Beqhibter N,et al.The prognostic value of CA19-9 in the preoperative work-up of pancreatic cancer patients[J].Harefuah,2006,145(11):793-794.
  • 8Coral V,Yesilbagdan H,Kaplan A,et al.Evaluation of CA72-4 as a new tumor marker in patients with gastric cancer[J].Hepatogastroenterology,2007,54(76):1272-1275.
  • 9Ucar E,Semerci E,Ustun H,et al.Prognostic value of preoparative CEA,CA 19-9,CA 72-4,and AFP levels in gastric cancer[J].Adv Ther,2008,25(10):1075-1084.
  • 10Gao ZL,Zhang C,Du GY,et al.Clinical significance of changes in tumor markers,extracellular matrix,MMP-9 and VEGF in patients with gastric carcinoma[J].Hepatogastroenterology,2007,54(77):1591-1595.

共引文献74

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部